Specialized brain imaging that measures amyloid burden can be used to quantify the biological severity of Alzheimer's-related pathology and can be expressed on a numerical scale to help estimate future risk of cognitive decline.
high
imaging
Use of amyloid imaging as a biomarker for Alzheimer's disease risk assessment